SINGAPORE, 14 APRIL 2022: Us2.ai, the Singapore-based medtech developers of FDA- cleared AI software that, for the first time ever, fully automates a complete echocardiography (heart ultrasound) report, today announced...
Art Pappas will be speaking on two panels, Starting Up Biotechs in the New Normal World and Success in the States: A Guide for Foreign Companies to the Largest Venture Capital Pool in the World, at the Bio 2011 conference in Washington, D.C.
News | 06. 29. 2011
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.